Contagious Aging: The Messenger in the Blood

Contagious Aging: The Messenger in the Blood Personal May 18, 2026 8 min /personal/contagious-aging/ A 2025 study from Korea University found that a single protein, ReHMGB1, can carry the signal of cellular aging through the bloodstream. Notes from a paper that is worth sitting with.

I came across a study last week that I have not been able to put down. It is from Professor Ok Hee Jeon's group at Korea University, published in Metabolism: Clinical and Experimental, and it argues something I had never quite considered before.

Aging, the paper says, is contagious. Not in a virus-on-the-bus way. In a quieter way. A protein released by old, worn-out cells travels through the bloodstream, reaches healthy cells far away, and tells them to start aging too. The signal does not just stay local. It spreads.

I want to write this one down because it is one of those findings that quietly changes the shape of a question. The question of why we age has always felt like a question about wear and tear. This paper makes it look more like a question about signaling.

Aging is not just something that happens cell by cell. It is something that spreads.

I am not a biologist. I am a person who has watched the people I love get older, and who has felt the slow shifts in my own body the way most people in their middle years do. The question I had carried around about aging was vague but firm. Why does it happen so unevenly. Why does one tissue go before another. Why does it feel less like a clock and more like a tide.

This paper offers a candidate answer. The tide moves because something is carrying the signal of it through the blood. That is not the only thing happening, but it is one of the things, and it is the first time I have read a paper that made the spread of aging feel mechanical and addressable, instead of inevitable.

The setup is worth getting right. When a cell takes enough damage, from stress, from UV exposure, from sheer time, it has a choice. It can die. It can become cancerous. Or it can stop dividing and sit there. The third path is called senescence. The cell does not die. It does not split. It just stays.

That sounds harmless. It is not. A senescent cell starts secreting a cocktail of inflammatory molecules into the space around it. The cocktail has a name: the Senescence-Associated Secretory Phenotype, or SASP. It is the cell saying, loudly and constantly, that something is wrong.

The local effect of the SASP has been understood for a while. It causes inflammation. It damages nearby tissue. What was not as clear, until this paper, was how much of that signal escapes the neighborhood and travels through the body.

The protein at the center of the story is called HMGB1. In a healthy cell, HMGB1 lives in the nucleus, helping to organize DNA. In a senescent cell, it gets released into the world outside the cell, and from there it can enter the bloodstream.

The interesting twist is that HMGB1 has two chemical forms, depending on whether it is oxidized or not. The Jeon group's finding is sharp. Only the reduced form, which they label ReHMGB1, carries the aging signal. The oxidized form does almost nothing in this context.

This study reveals that aging signals are not confined to individual cells but can be systemically transmitted via the blood, with ReHMGB1 acting as a key driver. Professor Ok Hee Jeon, Korea University College of Medicine

That single sentence is the change. The local picture of aging has been the standard picture for a long time. The systemic picture, that there is a circulating messenger doing the spreading, has been suspected but not pinned down. Pinning it down on a specific protein, with a specific redox state, is what makes this a real result and not a metaphor.

Here is the loop, in plain language. It is a feedback loop, which is the part that gives me pause.

• A senescent cell releases ReHMGB1 into the blood as part of its SASP.
• ReHMGB1 travels and reaches a healthy cell somewhere else in the body.
• It binds to a receptor on that cell called RAGE. RAGE acts like a doorbell.
• The doorbell triggers two internal pathways: NF-kB, which controls inflammation, and JAK/STAT, which controls stress and aging genes.
• The healthy cell stops dividing. It becomes senescent. It begins to secrete its own SASP, including more ReHMGB1.
• The loop closes. One zombie cell, in effect, recruits the next.

The team showed this pathway lights up across multiple human cell types: skin fibroblasts, kidney cells, and skeletal muscle cells. They confirmed it in living mice. Young mice injected with ReHMGB1 quickly showed signs of aging: more senescent cells, more inflammation, and measurably weaker muscles. Older mice, untreated, naturally carry higher levels of ReHMGB1 in their blood. The shape of the evidence fits the shape of the claim.

The reason this matters is that contagion is a different problem than wear and tear. Wear and tear is hard to fix because it is everywhere. A circulating messenger is, in principle, easier. You can target a messenger.

A circulating messenger is, in principle, easier to fix than a thousand local fires. You can target a messenger.

The same paper tested exactly that. They gave middle-aged mice with muscle injuries an antibody that neutralized HMGB1 in the blood. Compared with the untreated controls, those mice healed better. They had fewer senescent cells in the muscle. They recovered grip strength faster. They held up longer on a treadmill. None of this is a cure for aging. It is something more interesting. It is the first credible demonstration that interrupting one specific blood-borne signal can blunt one specific dimension of getting old.

The therapeutic doors that opens are predictable, but worth naming. Antibodies that neutralize ReHMGB1. Drugs that block the RAGE receptor. Drugs that interrupt the NF-kB or JAK/STAT pathways downstream. Interventions that keep HMGB1 inside the nucleus, where it belongs. None of these are ready for humans. All of them now have a target.

I do not write much about biology on this blog. I wanted to write this one because the framing of the result hit me harder than the result itself.

For most of my life, I have thought about aging as a property of cells. A cell gets old, then another cell gets old, and at some point the count tips over and you notice. The Jeon paper rearranges that mental model. Aging, at least in part, is a property of the system. The cells are talking to each other about it. One cell's surrender is another cell's instruction.

That is a small philosophical shift, and it carries a small practical consequence. The interventions that would matter most are not the ones that work on a single cell. They are the ones that quiet the conversation. The next generation of longevity science, if this line holds, is going to be about reading the messages and choosing which ones to let through.

I am not in a hurry to declare war on my own cells. I am sitting with the idea that some of what I have called inevitable is, on closer inspection, a signal that could in principle be turned down. That is not a promise. It is a different kind of question.

I wanted that question written down somewhere I could come back to.